Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

Novavax faces a couple of key issues that could be crucial for the stock price. Novavax ( NVAX 0.67% ) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a ...

It seems like a distant memory now, but Novavax (NVAX-1.43%) delivered a jaw-dropping 2,700% return in 2020. The stock was also a big winner throughout much of last year. But then the bottom ...

Covid-19 vaccine developer Novavax’s stock remained flat over the last week, compared to the broader Nasdaq-100 which declined by about 3%, amid concerns of surging U.S. inflation and the coming ...

Covid-19 vaccine developer Novavax’s stock has declined by almost 31% thus far in 2022, considerably underperforming the S&P 500, which is down by about -4.5% over the same period. Although U.S ...